Stoneridge Investment Partners’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-195,787
Closed -$7.32M 142
2018
Q1
$7.32M Buy
195,787
+47,643
+32% +$1.93M 1.23% 28
2017
Q4
$6.33M Sell
148,144
-81,631
-36% -$3.26M 1.01% 40
2017
Q3
$8.43M Buy
229,775
+72,246
+46% +$2.92M 1.33% 17
2017
Q2
$7.15M Buy
157,529
+86,615
+122% +$3.82M 1.07% 29
2017
Q1
$3.02M Hold
70,914
0.41% 89
2016
Q4
$2.85M Sell
70,914
-77,190
-52% -$2.98M 0.39% 94
2016
Q3
$5.75M Buy
148,104
+94,115
+174% +$3.55M 0.83% 24
2016
Q2
$1.87M Buy
+53,989
New +$1.87M 0.28% 113

Other funds holding HOLX

Stoneridge Investment Partners's HOLX Position: Q2 2018 in Review

Stoneridge Investment Partners sold out of Hologic (HOLX) in Q2 2018, closing a stake of 195,787 shares — an estimated $7.32M sold.

Stoneridge Investment Partners first reported a position in HOLX in Q2 2016 and held it in 8 quarters. The position peaked at $8.43M in Q3 2017. 450 funds tracked by Wall St. Rank hold HOLX as of Q2 2018.

  • Stoneridge Investment Partners reported no remaining Hologic position as of Q2 2018 after selling out during the quarter.
  • Stoneridge Investment Partners sold 195,787 Hologic shares in Q2 2018, an estimated $7.32M.
  • Stoneridge Investment Partners first reported a position in Hologic in Q2 2016 and held it in 8 quarters.
  • Stoneridge Investment Partners's Hologic position peaked at $8.43M in Q3 2017.
  • 450 funds tracked by Wall St. Rank held Hologic as of Q2 2018.

Based on Stoneridge Investment Partners's 13F filing for Q2 2018, filed 31 Jul 2018.